If you’re worried about COVID, there’s a simple way to boost protection: get vaccinated. But this doesn’t work for everyone. People with weak immune systems – perhaps because of age or a medical condition – don’t respond well to vaccines. For them, COVID still poses a significant risk.
But in November 2021, the UK approved a new drug for treating COVID, reducing this risk. Called molnupiravir, it can be taken orally at home. It’s been authorised for treating mild to moderate COVID in adults – specifically those at high risk of developing severe illness.
Data suggests the drug cuts the risk of hospitalisation or death by 30%, which could make a big difference to people with little immunity. The UK government estimates it could save thousands of lives once fully available across the NHS.
-copy-dd1f2bf0.jpeg?w=600)
